Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin-Lin Hou

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Journal of Gastroenterology and Hepatology|August 12, 2004
Practical difficulties in the management of hepatitis B in the Asia-Pacific regionRosmawati Mohamed, Paul Desmond, Dong-Jin Suh, et al.
Antiviral Research|August 19, 2018
HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland ChinaLai Wei, Masao Omata, Young-Suk Lim, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|November 20, 2003
[Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization]Qing-ling Zhang, Yan-qing Ding, Jin-lin Hou, et al.
The Lancet. Gastroenterology & Hepatology|July 13, 2023
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trialMan-Fung Yuen, Tarik Asselah, Ira M Jacobson, et al.
Hepatology International|August 12, 2009
Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and ThailandSiwaporn Chainuvati, Jun Cheng, Jin Lin Hou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
T cell responses to whole SARS coronavirus in humansChris Ka-fai Li, Hao Wu, Huiping Yan, et al.
Hepatology International|July 24, 2015
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patientsJi-Dong Jia, Jin-Lin Hou, You-Kuan Yin, et al.
Hepatology International|April 12, 2018
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b studyLai Wei, Qing Xie, Jin Lin Hou, et al.
Hepatology International|July 24, 2015
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateYun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Hepatology International|July 24, 2015
Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateYun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Journal of Gastroenterology and Hepatology|August 12, 2004
Practical difficulties in the management of hepatitis B in the Asia-Pacific regionRosmawati Mohamed, Paul Desmond, Dong-Jin Suh, et al.
Antiviral Research|August 19, 2018
HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland ChinaLai Wei, Masao Omata, Young-Suk Lim, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|November 20, 2003
[Detection of severe acute respiratory syndrome (SARS)-associated coronavirus RNA in autopsy tissues with in situ hybridization]Qing-ling Zhang, Yan-qing Ding, Jin-lin Hou, et al.
The Lancet. Gastroenterology & Hepatology|July 13, 2023
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trialMan-Fung Yuen, Tarik Asselah, Ira M Jacobson, et al.
Hepatology International|August 12, 2009
Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and ThailandSiwaporn Chainuvati, Jun Cheng, Jin Lin Hou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
T cell responses to whole SARS coronavirus in humansChris Ka-fai Li, Hao Wu, Huiping Yan, et al.
Hepatology International|July 24, 2015
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patientsJi-Dong Jia, Jin-Lin Hou, You-Kuan Yin, et al.
Hepatology International|April 12, 2018
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b studyLai Wei, Qing Xie, Jin Lin Hou, et al.
Hepatology International|July 24, 2015
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateYun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Hepatology International|July 24, 2015
Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 updateYun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Pageof 15